Podcasts
-
Benefits Of Applying Analytical Quality By Design To Enhance Analytical Controls
2/28/2022
Dr. Mark Argentine, Senior Research Advisor of Eli Lilly, discusses the benefits at Analytical Quality by Design, the challenges of identifying impurities and drug degradants, and regulatory and compliance barriers to enhance analytical controls.
-
Applying AQbD Principles To Vaccine Development
2/23/2022
In this podcast, host Arjan Timmerman talks with Janssen senior scientist, Dr. Ewoud van Tricht, about how he approaches vaccine development with an analytical quality by design approach.
-
Janssen's Stepwise Approach To AQbD And Vaccine Development
2/23/2022
In this podcast Dr. Ewoud van Tricht elaborates on the specific steps of AQbD and the advantages gained.
-
The Nitrosamine Crisis: Controlling Risk By Leveraging MLCM Principles – Part 1
2/21/2022
In part one of a 3-part series on the Nitrosamine crisis, Dr. Andrew Teasdale of AstraZeneca discusses regulatory expectations, reporting requirements, and minimizing risk relative to solvent contamination.
-
Components Of A Successful AQbD Workflow
2/21/2022
In this podcast we discuss the various components of the AQbD workflow including: the analytical target profile, method design, method validation, and performance verification.
-
Harness The Power Of QbD Principles
2/2/2022
This podcast discusses instrument QbD and its role in developing a successful QbD plan, reviewing the importance of knowledge gathering, validation, qualification, and critical thinking within the lab.
-
Data-Driven Modeling Approaches To Improve Method Development
2/1/2022
Pfizer's Dr. Pankaj Aggarwal discusses the use of data-driven modeling to build quality and robustness into analytical methods.